Onito, Marcedita G.
HRN: 21-81-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CEFUROXIME 500MG (TAB)
08/17/2022
08/25/2022
PO
500mg
Q12
Septic Incomplete Abortion
Waiting Final Action
Indication: ProphylaxisEmpirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes